Skip to content
This GLP
Updated September 2026The refill doubles it

Eloria review

The headline rate covers a first month, and the figure that follows it lives only in the FAQ.

The verdict

Eloria leads with $149 for its GLP-1 injection plan, and its own FAQ states that refills are then locked in at $299, which is a little over double. No card on the page carries the second figure, and the dissolving tablet line is $249 with no opening rate attached.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide
Form
Injection · Oral
Injection
From $299/mo
Oral
From $249/mo
Dose published
No
Prescription
Required
Compounded
Yes — not FDA-approved
Pharmacy
Not named

Eloria is a cash-pay weight-care service whose product row holds five cards: a weekly GLP-1 injection, a daily GLP-1 dissolving tablet, and brand Wegovy as either a pill or an injection alongside brand Zepbound. The three brand cards are priced as a $99 membership plus whatever the medication costs, with availability described as subject to change, so a reader cannot learn from this page what a brand month would actually cost.

  1. Who writes the prescription, and what do they see?

    A board-certified provider licensed in the patient's own state reviews a health questionnaire that Eloria says takes about five minutes, and the prescription then goes to a partner pharmacy. Unlimited appointments, messaging and support are described as available at any hour, with a dedicated team of specialists behind them. No clinician, medical group or medical director is named anywhere, and no list of covered states appears.

    The program is cash-pay by design, which Eloria presents as the reason its pricing stays simple, and health savings and flexible spending cards are accepted for most visits and medications. There are no contracts. The FAQ answers are unusually complete for a page this short, and they are also where the price actually lives, which is the opposite of how most sellers arrange the same information.

  2. What happens when the dose goes up?

    Nothing on the page describes what happens across the dose ladder. There is no milligram, no escalation schedule and no statement about whether the charge moves as the dose rises, which leaves a buyer unable to tell whether the $299 refill rate is the ceiling or the first rung of one. The only movement the page documents is the step from the first month to every month after it.

  3. What the price includes

    The injection card says starting at $149 and the tablet card says starting at $249. The FAQ answering what the program costs says a patient starts from $149 for the first month and that refills are locked in at $299 with the same benefits included. That makes $149 an opening rate rather than a price, and $299 the figure a reader budgeting for a year should be using.

  4. What it claims, and what it cites

    The compounded preparations are made in FDA-regulated facilities for individual patients and are not FDA-approved, which Eloria states in the FAQ rather than in a footnote. The partner pharmacies are described as state-licensed and are not named. The compounded molecule is never identified: the cards read GLP-1 injections and GLP-1 tablets, and neither semaglutide nor tirzepatide appears anywhere on the page, though both Wegovy and Zepbound are named on the brand cards.

Where it holds up, and where it does not

  • Strength: The refill rate is published, even if only in the FAQ
  • Strength: Brand and compounded options sit on one row
  • Strength: Cash-pay with no contract and no insurance step
  • Strength: Unlimited messaging and appointments included
  • Limitation: The headline $149 covers one month only
  • Limitation: Refills are $299, and no card shows it
  • Limitation: The compounded molecule is never named
  • Limitation: The three brand cards carry no medication price at all
  • Limitation: Every FAQ link points at the site template's designer

What the evidence says about this kind of treatment

The assessment above is about Eloria. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader who will budget on the refill rate rather than the opening one.
Wrong for
A reader who needs to know which molecule a $299 month is buying.

How Eloria compares

SellerWho it suitsGo
AmbleBuyers who want a multi-month rate and will ask which molecule before orderingSee Amble
MondaeBuyers who want a low published compounded rate and few other detailsSee Mondae
ReflexMDBuyers who want the compounded rate on the homepage rather than after an intakeSee ReflexMD
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: LevelUp RxLevers HealthLibertyLifeMDLiv BodyLive Vital

Sponsored alternative

Bodybuilding Health+

A reader unwilling to prepay a year before seeing how the drug goes

Check Bodybuilding Health+ availability →

Frequently asked

What does a second month cost?
$299. Eloria's FAQ states the program starts from $149 for the first month and that refills are then locked in at that rate.
Which GLP-1 is prescribed?
Not named. The compounded cards say GLP-1 injections and GLP-1 tablets, and neither molecule appears on the page.
What do the brand options cost?
A $99 membership plus the cost of the medication, which is not published. Availability is described as subject to change.
Is Eloria expensive compared with other GLP-1 telehealth sellers?
Eloria publishes a starting figure of $249/mo. Across the 252 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $399 with a median of $178, which puts Eloria above the median. The other 19 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Ruth AlvarezOutcomes writer · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from Eloria’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.